Ablynx Banks $200M IPO in Nasdaq Debut Post author:Sam Post published:October 24, 2017 Post category:BioPharma Ablynx announced the price of its U.S. IPO at $17.50. Source: BioSpace You Might Also Like It's Finally Happening: Johnson & Johnson Pays $30 Billion for Actelion, Will Spin Off R&D Unit With $1 Billion Cash January 25, 2017 Heads Up Startups: Silicon Valley VC Firm—With an Appetite for Biotech—Nabs Record $800 Million Fund July 25, 2017 <b>Affinity Bio</b> Partners And <b>Affinity Bioceuticals</b> September 20, 2017
It's Finally Happening: Johnson & Johnson Pays $30 Billion for Actelion, Will Spin Off R&D Unit With $1 Billion Cash January 25, 2017
Heads Up Startups: Silicon Valley VC Firm—With an Appetite for Biotech—Nabs Record $800 Million Fund July 25, 2017
